Total Payments
$10,541
2024 Payments
$1,522
Companies
48
Transactions
702
Medicare Patients
3,624
Medicare Billing
$194,264
Payment Breakdown by Category
Food & Beverage$10,515 (99.8%)
Education$25.18 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,515 | 700 | 99.8% |
| Education | $25.18 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,098 | 145 | $0 (2024) |
| Lilly USA, LLC | $884.49 | 60 | $0 (2024) |
| PFIZER INC. | $881.58 | 65 | $0 (2024) |
| GlaxoSmithKline, LLC. | $582.11 | 45 | $0 (2024) |
| Abbott Laboratories | $566.63 | 34 | $0 (2024) |
| ABBVIE INC. | $482.54 | 34 | $0 (2024) |
| Astellas Pharma US Inc | $455.15 | 29 | $0 (2021) |
| Bayer Healthcare Pharmaceuticals Inc. | $391.92 | 24 | $0 (2024) |
| Merck Sharp & Dohme LLC | $382.71 | 36 | $0 (2023) |
| Amgen Inc. | $373.71 | 23 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,522 | 78 | Abbott Laboratories ($210.63) |
| 2023 | $1,960 | 119 | Novo Nordisk Inc ($320.66) |
| 2022 | $1,495 | 106 | Novo Nordisk Inc ($299.74) |
| 2021 | $162.26 | 9 | Astellas Pharma US Inc ($66.52) |
| 2020 | $317.89 | 24 | Novo Nordisk Inc ($149.39) |
| 2019 | $1,512 | 107 | Novo Nordisk Inc ($387.01) |
| 2018 | $1,944 | 131 | Novo Nordisk Inc ($520.55) |
| 2017 | $1,628 | 128 | Novo Nordisk Inc ($228.37) |
All Payment Transactions
702 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: PSYCHIATRY | ||||||
| 12/05/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $9.27 | General |
| 12/04/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/03/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: Cardio-renal | ||||||
| 11/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $11.23 | General |
| Category: RESPIRATORY | ||||||
| 11/20/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: PSYCHIATRY | ||||||
| 10/25/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $27.56 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 10/24/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $11.34 | General |
| Category: RESPIRATORY | ||||||
| 10/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: Gastroenterology | ||||||
| 10/16/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: Diabetes Care | ||||||
| 10/16/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $12.22 | General |
| Category: VACCINES | ||||||
| 10/08/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: Cardio-renal | ||||||
| 10/07/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: Diabetes | ||||||
| 10/04/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $24.71 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 09/30/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: Diabetes | ||||||
| 09/26/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: Inflammation | ||||||
| 09/24/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Obesity | ||||||
| 09/23/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/18/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: Diabetes Care | ||||||
| 09/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: RESPIRATORY | ||||||
| 09/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: RESPIRATORY | ||||||
| 09/13/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $31.13 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 09/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: Cardio-renal | ||||||
| 08/27/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $12.22 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 930 | 1,401 | $186,563 | $50,231 |
| 2022 | 22 | 1,001 | 1,491 | $186,387 | $47,000 |
| 2021 | 19 | 859 | 1,288 | $169,331 | $53,904 |
| 2020 | 15 | 834 | 1,187 | $150,427 | $43,129 |
Total Patients
3,624
Total Services
5,367
Medicare Billing
$194,264
Procedure Codes
75
All Medicare Procedures & Services
75 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 175 | 407 | $91,168 | $16,805 | 18.4% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 40 | 40 | $23,320 | $11,258 | 48.3% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 67 | 68 | $9,180 | $5,063 | 55.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 118 | 118 | $28,442 | $4,548 | 16.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 56 | 70 | $11,060 | $2,574 | 23.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 76 | 77 | $3,927 | $2,208 | 56.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 145 | 243 | $1,701 | $1,661 | 97.6% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 12 | 12 | $4,176 | $1,616 | 38.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 40 | 40 | $1,880 | $1,147 | 61.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 29 | 87 | $4,437 | $730.88 | 16.5% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 21 | 21 | $1,365 | $692.40 | 50.7% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 14 | 28 | $1,008 | $454.16 | 45.1% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 22 | 26 | $962.00 | $405.00 | 42.1% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 29 | 35 | $910.00 | $317.76 | 34.9% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 23 | 24 | $1,488 | $266.58 | 17.9% |
| 72110 | X-ray of lower and sacral spine, minimum of 4 views | Office | 2023 | 11 | 11 | $693.00 | $198.08 | 28.6% |
| 83037 | Hemoglobin a1c level, by device for home use | Office | 2023 | 21 | 21 | $441.00 | $192.20 | 43.6% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 14 | 53 | $265.00 | $50.31 | 19.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 17 | 20 | $140.00 | $44.00 | 31.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 149 | 369 | $82,656 | $13,669 | 16.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 29 | 29 | $16,907 | $7,510 | 44.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 85 | 87 | $11,745 | $5,952 | 50.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 113 | 113 | $27,233 | $4,090 | 15.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 62 | 88 | $13,904 | $3,148 | 22.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 92 | 94 | $4,794 | $2,554 | 53.3% |
About Dr. Christopher Chow, MD
Dr. Christopher Chow, MD is a Family Medicine healthcare provider based in Broken Arrow, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1538111976.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Chow, MD has received a total of $10,541 in payments from pharmaceutical and medical device companies, with $1,522 received in 2024. These payments were reported across 702 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($10,515).
As a Medicare-enrolled provider, Chow has provided services to 3,624 Medicare beneficiaries, totaling 5,367 services with total Medicare billing of $194,264. Data is available for 4 years (2020–2023), covering 75 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Broken Arrow, OK
- Active Since 05/16/2006
- Last Updated 05/01/2014
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1538111976
Products in Payments
- Saxenda (Drug) $550.40
- Ozempic (Drug) $472.73
- TRELEGY ELLIPTA (Drug) $417.75
- MYRBETRIQ (Drug) $410.89
- Kerendia (Drug) $391.92
- FREESTYLE LIBRE 3 (Device) $357.91
- Livalo (Drug) $348.45
- VRAYLAR (Drug) $328.69
- MOUNJARO (Drug) $317.57
- Victoza (Drug) $297.89
- Azstarys (Drug) $295.28
- CHANTIX (Drug) $287.65
- JANUVIA (Drug) $260.99
- JARDIANCE (Drug) $233.33
- ENTRESTO (Drug) $226.61
- XARELTO (Drug) $217.01
- Rybelsus (Drug) $209.11
- TRULICITY (Drug) $206.31
- ELIQUIS (Drug) $201.01
- Vascepa (Drug) $169.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Broken Arrow
Dr. James Campbell, D.o, D.O
Family Medicine — Payments: $43,510
Family Medicine $43,510
Dr. Ronald Oglesby, D.o, D.O
Family Medicine — Payments: $14,016
Family Medicine $14,016
Dr. Beau Jennings, Do, DO
Family Medicine — Payments: $12,231
Family Medicine $12,231
Coy Peters, D.o, D.O
Family Medicine — Payments: $9,170
Family Medicine $9,170
Michael Sayler, D.o, D.O
Family Medicine — Payments: $9,088
Family Medicine $9,088
Christopher Guinn, Do, DO
Family Medicine — Payments: $7,779
Family Medicine $7,779